Brief: Harrow Health Announces Fourth Quarter Results
March 23 (Reuters) - Harrow Health Inc HROW.O :
* HARROW ANNOUNCES FOURTH QUARTER AND YEAR-END 2022
FINANCIAL
RESULTS
* QTRLY NET REVENUE $20.3 MILLION VERSUS $20.2 MILLION
* QTRLY BASIC AND DILUTED NET INCOME PER SHARE $0.04
* Q4 EARNINGS PER SHARE VIEW $-0.12, REVENUE VIEW $21.4
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nBw6md3mpa
Further company coverage: HROW.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates